Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.


Substance Use and Addiction Conference; Washington DC; 2018

Event Details

Previous Page


Invited Paper Session #6
Verbal Behavior Approaches to Treatment
Tuesday, November 20, 2018
8:00 AM–10:30 AM
Independence Hall A
Domain: Service Delivery
Instruction Level: Basic
CE Instructor: Mark Galizio, Ph.D.
Chair: Mark Galizio (University of North Carolina Wilmington)
Discussant: Jonathan Bricker (University of Washington)
Acceptance and Commitment Therapy: Understanding and Treating Addiction
KELLY WILSON (University of Mississippi)
Kelly G. Wilson, Ph.D., is a Professor of Psychology at the University at Mississippi. He is Past President of the Association for Contextual Behavioral Science, Representative-at-Large of the Society for a Science of Clinical Psychology, and is one of the co-founders of Acceptance and Commitment Therapy. Dr. Wilson received his B.A. Summa Cum Laude from Gonzaga University and his Ph.D. at the University of Nevada, Reno. After running a National Institutes on Drug Abuse clinical trial in Reno, he joined the faculty at the University of Mississippi in 2000 where he established the Mississippi Contextual Psychology Lab. Dr. Wilson is a devoted mentor a university-wide Elsie M. Hood Award for undergraduate teaching and also the University of Mississippi Award for Excellence in Graduate Teaching and Mentoring. Dr. Wilson has devoted himself to the development and dissemination of Acceptance and Commitment Therapy, Relational Frame Theory, and their underlying theory and philosophy for the past 28 years, publishing 53 articles, 37 chapters, and 10 books. He has central interests in the application of behavioral principles to understanding topics such as purpose, meaning, values, therapeutic relationship, and present moment focused work. Dr. Wilson has presented his research in 32 countries, and has participated as co-investigator in a wide range of research projects in the U.S. and internationally.
Abstract: Substance use disorders remain among the most difficult to treat psychological problems. Psychologists often avoid this area. They frequently have minimal training in the treatment of substance use disorders and relapse rates remain high even using our best-developed treatments. In this presentation, we will examine recovery from addiction and barriers to recovery through the lens of the psychological flexibility model. A broadly contextual model will be contrasted with narrow disease-oriented perspective. The application of behavioral principles to a verbally established sense of self and life-purpose will be examined.
Cognitive Behavioral Therapy for Substance Use Disorders: Development and Evaluation of a Computerized CBT Program
BRIAN KILUK (Yale School of Medicine )
I received my Ph.D. in clinical psychology in 2009 from the University of Maryland, Baltimore County, completed postdoctoral training at Yale through a National Institute on Drug Abuse T32 Fellowship, and ultimately joined the faculty ranks in the Department of Psychiatry in 2012. My area of research includes an emphasis on three major topics: (1) the evaluation and enhancement of a web-based version of cognitive behavioral therapy for alcohol and drug use disorders (CBT4CBT); (2) exploration of the mechanisms of cognitive behavioral therapy (CBT) for substance use disorders, and (3) the identification of clinically meaningful outcome indicators of clinical trials for illicit drug use disorders. I have received research grants from the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, and my work has been featured at national scientific meetings. As an expert in CBT for substance use disorders, I have consulted with treatment facilities across the U.S. to provide workshop training in manual-guided CBT, as well as ongoing fidelity monitoring and coaching.
Abstract: Cognitive behavioral therapy (CBT) has strong empirical support for the treatment of various substance use disorders, yet it has been difficult to successfully implement in community treatment centers despite considerable effort toward dissemination. Technology-based interventions offer the potential to close the gap between research and clinical practice by providing a broadly accessible, standardized, cost-effective, and engaging method of delivering evidence-based treatments directly to clients, while also freeing up clinician time to address clients’ various psychosocial and case management needs. Moreover, from a research standpoint, the standardized delivery of treatment ingredients offers the potential for more precise evaluation of the interventions’ mechanisms of behavior change, compared to prior investigations that have been hindered by therapist variability with respect to fidelity, dose and quality of delivery. This session will focus on the development, evaluation, and implementation of one such technology-based intervention for substance use disorders, “Computer Based Training for Cognitive Behavioral Therapy” (CBT4CBT). Data will be presented from two completed randomized controlled trials supporting the efficacy of CBT4CBT as an adjunct to standard substance abuse treatment (Carroll et al., 2008; Carroll et al., 2014), as well as two recently completed trials supporting the safety and efficacy of CBT4CBT as a stand-alone treatment (Kiluk et al., 2016; Kiluk et al., under review). Factors considered during the design/development phase of the intervention, as well as the characteristics of ongoing trials that are intended to advance the understanding of mechanisms will be discussed. Finally, the session will conclude with a discussion of the future directions of CBT4CBT, which include attempts to improve treatment outcomes and dissemination strategies.
Target Audience:

Board certified behavior analysts; licensed psychologists; graduate students.

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) describe how operant conditioning can be used to promote drug abstinence and adherence to medications; (2) describe parameters of operant conditioning that are critical to promoting drug abstinence in refractory patients and maintaining drug abstinence over time; (3) describe the main features of the therapeutic workplace; (4) describe how the therapeutic workplace uses contingent access to employment (i.e., employment-based reinforcement) to promote drug abstinence, medication adherence, work, and productivity; (5) describe three models for arranging long-term exposure to employment-based reinforcement in the treatment of drug addiction; (6) describe the theoretical link between mindfulness and acceptance processes and behavioral principles; (7) describe the theoretical link between values and behavioral activation processes and behavioral principles; (8) describe methods of directly linking valued action to mindfulness practices in the treatment of addiction.



Back to Top
Modifed by Eddie Soh